Axsome Therapeutics Cash Flow from Operating Activities 2014-2025 | AXSM
Axsome Therapeutics cash flow from operating activities for the twelve months ending June 30, 2025 was $-0.350B, a 11.86% decline year-over-year.
- Axsome Therapeutics annual cash flow from operating activities for 2024 was $-0.128B, a 11.49% decline from 2023.
- Axsome Therapeutics annual cash flow from operating activities for 2023 was $-0.145B, a 24.52% increase from 2022.
- Axsome Therapeutics annual cash flow from operating activities for 2022 was $-0.117B, a 7.66% increase from 2021.